Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
Go back to Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer| (NASDAQ: AKTX) | Delayed: 7.54 +0.54 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.00 | 52 Week High | $19.75 | |||
| Open | $7.01 | 52 Week Low | $7.63 | |||
| Day High | $7.99 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $0.00 | |||
| Volume | 164,324 | |||||
| (NASDAQ: AKTX) | Delayed: 7.54 +0.54 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.00 | 52 Week High | $19.75 | |||
| Open | $7.01 | 52 Week Low | $7.63 | |||
| Day High | $7.99 | P/E | N/A | |||
| Day Low | $6.51 | EPS | $0.00 | |||
| Volume | 164,324 | |||||
